Department of Pathology and Laboratory Medicine, Institute on Aging and Center for Neurodegenerative Disease Research, University of Pennsylvania School of Medicine, Philadelphia, PA, 19104-2676, USA.
Department of Cell Biology and Neuroscience, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Nat Commun. 2023 Oct 28;14(1):6892. doi: 10.1038/s41467-023-42705-5.
Extraction of α-Synuclein (αSyn) aggregates from Lewy body disease (LBD) brains has been widely described yet templated fibrillization of LB-αSyn often fails to propagate its structural and functional properties. We recently demonstrated that aggregates amplified from LB-αSyn (ampLB) show distinct biological activities in vitro compared to human αSyn preformed fibrils (hPFF) formed de novo. Here we compare the in vivo biological activities of hPFF and ampLB regarding seeding activity, latency in inducing pathology, distribution of pathology, inclusion morphology, and cell-type preference. Injection of ampLB into mice expressing only human αSyn (male Thy1:SNCA/Snca mice) induced pathologies similar to those of LBD subjects that were distinct from those induced by hPFF-injection or developing spontaneously with aging. Importantly, αSyn aggregates in ampLB-injected Thy1:SNCA/Snca mice maintained the unique biological and conformational features of original LB-αSyn. These results indicate that ampLB-injection, rather than conventional PFF-injection or αSyn overexpression, faithfully models key aspects of LBD.
从路易体病 (LBD) 大脑中提取α-突触核蛋白 (αSyn) 聚集体已被广泛描述,但 LB-αSyn 的模板纤维化往往无法传播其结构和功能特性。我们最近证明,从 LB-αSyn 中扩增的聚集体 (ampLB) 在体外表现出与从头形成的人 αSyn 原纤维 (hPFF) 不同的生物学活性。在这里,我们比较了 hPFF 和 ampLB 在种子活性、诱导病理学潜伏期、病理学分布、包含形态和细胞类型偏好方面的体内生物学活性。将 ampLB 注射到仅表达人 αSyn 的小鼠体内 (雄性 Thy1:SNCA/Snca 小鼠) 会诱导出类似于 LBD 患者的病理学,与 hPFF 注射或随年龄自然发展引起的病理学不同。重要的是,ampLB 注射诱导的 Thy1:SNCA/Snca 小鼠中的 αSyn 聚集体保持了原始 LB-αSyn 的独特生物学和构象特征。这些结果表明,ampLB 注射而不是传统的 PFF 注射或 αSyn 过表达能够忠实地模拟 LBD 的关键方面。